Abstract
John Hannah, 90, died March 14, 2022, in Sebastopol, California. “Born in Ayrshire, Scotland, John moved to Cambridge, Massachusetts, after he earned a PhD to work under R. B. Woodward on the total synthesis of chlorophyll, and then moved to Cambridge, England, to work under Alexander Todd. At Merck & Co., he worked on anti-inflammatory agents and discovered the novel salicylic acid derivative diflunisal. John later discovered a new class of heterocyclylamino penicillins and cephalosporins antibiotics. Many may remember John from his oversight of the Merck & Co. Chemistry Department’s recruiting program at Harvard University and the Massachusetts Institute of Technology. After retirement, John moved to California where he enjoyed life in the Sonoma wine world.”—Alison Hannah, daughter Most recent title: Senior investigator, Merck & Co. Education: BSc, chemistry, University of Glasgow, 1953; PhD, chemistry, Imperial College London, 1956 Survivors: Son, Robert; daughter, Alison; five grandchildren To recognize your late
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
